Rheumatoid Arthritis Clinical Trial
Official title:
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
This study will be an open-label prospective analysis of oral prednisone (compared to IV
methylprednisolone) as a pre-treatment for rituximab in patients with rheumatoid arthritis.
The study will be useful as pilot data to establish that there are no different trends
between the two treatment strategies at decreasing the frequency and severity of acute
infusion reactions. It would also establish proof of principle that pre-treatment with oral
prednisone is equally as efficacious as IV methylprednisolone.
The primary endpoint will be to assess the safety and tolerability of rituximab (Rituxan) in
RA.
By showing that there are no differences in the frequency or severity of acute infusion
reactions after rituximab when using pre-treatment with oral prednisone compared to I.V.
methylprednisolone, we will establish proof of principle that oral prednisone is a viable
alternative to I.V. methylprednisolone. Pre-treatment with oral prednisone would be a
practical advantage for both the patient and the treating physician. The patient could
self-administer this treatment at home thereby decreasing the time they would need to spend
at the infusion center. Further, this dose of prednisone has fewer side effects than 100mg of
methylprednisolone.
This study will be an open-label prospective analysis of oral prednisone (compared to IV
methylprednisolone) as a pre-treatment for rituximab in patients with rheumatoid arthritis.
The study will be useful as pilot data to establish that there are no different trends
between the two treatment strategies at decreasing the frequency and severity of acute
infusion reactions. It would also establish proof of principle that pre-treatment with oral
prednisone is equally as efficacious as IV methylprednisolone.
The primary endpoint will be to assess the safety and tolerability of rituximab (Rituxan) in
RA.
By showing that there are no differences in the frequency or severity of acute infusion
reactions after rituximab when using pre-treatment with oral prednisone compared to I.V.
methylprednisolone, we will establish proof of principle that oral prednisone is a viable
alternative to I.V. methylprednisolone. Pre-treatment with oral prednisone would be a
practical advantage for both the patient and the treating physician. The patient could
self-administer this treatment at home thereby decreasing the time they would need to spend
at the infusion center. Further, this dose of prednisone has fewer side effects than 100mg of
methylprednisolone..
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |